Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario.

Flavia A Duarte Carlos Gil Ferreira Rodrigo DienstmannBruno L FerrariMatheus Costa E SilvaPedro Nazareth A JuniorPaulo Guilherme de Oliveira Salles Paulo Henrique Costa Diniz

Published in: Journal of market access & health policy (2022)

Our data show a long median time from advanced nsNSCLC diagnosis and the availability of the biomarker testing in medical practice, which impacted the choice of a non-personalized therapy as the first-line.

Keyphrases

healthcare
primary care
quality improvement
cell therapy
single cell
electronic health record
stem cells
machine learning
decision making
bone marrow
data analysis